Journal rankings · indicator year 2016
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Field ranking · 2016
Pharmacology, Toxicology and Pharmaceutics journal rankings 2016
74 ranked journals · Field in Life Sciences
Pharmacology, Toxicology and Pharmaceutics has 74 ranked journals in 2016. The median OJR fell 0.11 on 2015 to 0.61, below the world average of 1.00; Q1 starts at OJR 1.13. The top three are Expert Opinion on Drug Delivery, European Journal of Pharmaceutics and Biopharmaceutics, and Journal of Drug Delivery.
Ranks and citation indicators: 2016. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2013–2015, the window the 2016 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields in Pharmacology, Toxicology and Pharmaceutics (4)
Up to Life Sciences74 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2015. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2013–2015, the window the 2016 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2013–2015 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2007 to 2016. | Compare |
|---|---|---|---|---|---|---|---|
1Expert Opinion on Drug DeliveryTaylor & Francis · United Kingdom | 2.32Q1 | 5.35 0.26 up from 2015 | 428 | 32% | — | ||
2European Journal of Pharmaceutics and BiopharmaceuticsElsevier BV · Netherlands | 1.95Q1 | 4.61 0.45 up from 2015 | 837 | 20% | $4,210 | ||
3Journal of Drug DeliveryHindawi Publishing Corporation · United Kingdom | 1.84Q1 | 2.78 2.74 down from 2015 | 62 | 93% | — | ||
4Drug SafetyAdis, Springer Healthcare · New Zealand | 1.81Q1 | 4.01 0.22 down from 2015 | 336 | 38% | $4,990 | ||
5International Journal of PharmaceuticsElsevier BV · Netherlands | 1.70Q1 | 3.95 0.29 down from 2015 | 2,433 | 22% | $4,650 | ||
6European Journal of Pharmaceutical SciencesOAElsevier BV · Netherlands | 1.70Q1 | 3.51 0.20 down from 2015 | 836 | 21% | $3,070 | ||
7Forensic ToxicologySpringer Science+Business Media · Japan | 1.69Q1 | 4.33 0.05 up from 2015 | 128 | 20% | $2,990 | ||
8Drug Metabolism and DispositionAmerican Society for Pharmacology and Experimental Therapeutics · United States | 1.68Q1 | 3.99 0.37 up from 2015 | 696 | 38% | $3,500 | ||
9Expert Opinion on Drug SafetyTaylor & Francis · United Kingdom | 1.58Q1 | 3.92 0.21 up from 2015 | 412 | 22% | — | ||
10Expert Opinion on Drug Metabolism & ToxicologyTaylor & Francis · United Kingdom | 1.58Q1 | 3.49 0.48 up from 2015 | 418 | 27% | — | ||
11The Pharmacogenomics JournalSpringer Nature · United Kingdom | 1.58Q1 | 3.67 0.04 up from 2015 | 229 | 46% | $4,890 | ||
12Pharmaceutical ResearchSpringer Science+Business Media · United States | 1.50Q1 | 3.44 0.19 down from 2015 | 845 | 33% | $4,690 | ||
13Journal of Analytical ToxicologyOxford University Press · United Kingdom | 1.45Q1 | 2.57 0.24 up from 2015 | 398 | 33% | $4,823 | ||
14Critical Reviews in Therapeutic Drug Carrier SystemsBegell House · United States | 1.39Q1 | 2.40 3.57 down from 2015 | 46 | 5% | — | ||
15Current Drug MetabolismBentham Science Publishers · Netherlands | 1.38Q1 | 2.98 0.07 down from 2015 | 235 | 10% | — | ||
16Drug Testing and AnalysisWiley · United States | 1.35Q1 | 3.28 0.09 up from 2015 | 466 | 30% | $4,440 | ||
17Pharmacogenetics and GenomicsLippincott Williams & Wilkins · United Kingdom | 1.32Q1 | 2.45 0.65 down from 2015 | 256 | 45% | — | ||
18Drug Delivery and Translational ResearchSpringer Science+Business Media · United States | 1.21Q1 | 3.01 0.75 up from 2015 | 146 | 35% | $4,690 | ||
19PharmacogenomicsFuture Medicine · United Kingdom | 1.13Q1 | 2.64 0.01 down from 2015 | 590 | 31% | — | ||
20Journal of Pharmaceutical InnovationSpringer Science+Business Media · United Kingdom | 1.09Q2 | 2.24 0.17 up from 2015 | 97 | 7% | $3,990 | ||
21Biopharmaceutics & Drug DispositionWiley · United Kingdom | 1.07Q2 | 2.32 0.10 up from 2015 | 147 | 32% | $3,800 | ||
22AAPS PharmSciTechSpringer Science+Business Media · United States | 1.06Q2 | 2.27 0.18 up from 2015 | 547 | 23% | $4,190 | ||
23Drug Metabolism and Personalized TherapyDe Gruyter · Germany | 1.03Q2 | 1.59 1.13 down from 2015 | 34 | 11% | $2,712 | ||
24Therapeutic DeliveryFuture Science Ltd · United Kingdom | 0.98Q2 | 2.17 0.18 down from 2015 | 339 | 30% | — | ||
25Drug Metabolism and PharmacokineticsElsevier BV · Japan | 0.96Q2 | 1.97 0.21 up from 2015 | 204 | 19% | $3,580 | ||
26Drug metabolism and drug interactionsDe Gruyter · Germany | 0.95Q2 | 2.12 0.72 up from 2015 | 65 | — | — | ||
27Assay and Drug Development TechnologiesMary Ann Liebert, Inc. · United States | 0.94Q2 | 2.47 0.72 up from 2015 | 161 | 28% | — | ||
28Drug DeliveryOATaylor & Francis · United Kingdom | 0.91Q2 | 2.52 0.15 up from 2015 | 502 | 66% | $2,864 | ||
29XenobioticaTaylor & Francis · United Kingdom | 0.87Q2 | 1.70 0.17 up from 2015 | 378 | 22% | — | ||
30Clinical and Translational ScienceOAWiley · United Kingdom | 0.85Q2 | 1.29 0.12 up from 2015 | 267 | 100% | $3,630 | ||
31Journal of Fluorine ChemistryElsevier BV · Netherlands | 0.83Q2 | 2.24 0.05 up from 2015 | 731 | 8% | $3,660 | ||
32Drug Development and Industrial PharmacyTaylor & Francis · United States | 0.79Q2 | 1.99 0.09 down from 2015 | 592 | 20% | — | ||
33Journal of MicroencapsulationTaylor & Francis · United Kingdom | 0.78Q2 | 1.79 0.18 up from 2015 | 231 | 13% | — | ||
34Current Drug DeliveryBentham Science Publishers · Netherlands | 0.78Q2 | 1.79 0.28 up from 2015 | 241 | 4% | — | ||
35Journal of Pharmaceutical Health Care and SciencesOABioMed Central · United Kingdom | 0.72Q2 | 1.25no 2015 value | 36 | 100% | $2,490 | — | |
36Journal of PharmaceuticsOAHindawi Publishing Corporation · United Kingdom | 0.70Q2 | 2.04 0.77 up from 2015 | 52 | 100% | — | ||
37Pharmaceutical Development and TechnologyTaylor & Francis · United States | 0.61Q2 | 1.60 0.33 up from 2015 | 380 | 13% | — | ||
38Scientia PharmaceuticaOAÖsterreichische Apotheker-Verlagsgesellschaft m. b. H. · Switzerland | 0.61Q3 | 1.04 0.34 down from 2015 | 192 | 100% | $1,207 | ||
39Drug Metabolism LettersBentham Science Publishers · Netherlands | 0.59Q3 | 1.16 0.14 up from 2015 | 67 | 15% | — | ||
40Recent Patents on Drug Delivery & FormulationBentham Science Publishers · Netherlands | 0.56Q3 | 1.11 0.22 down from 2015 | 77 | 0% | — | ||
41Journal of Drug Delivery Science and TechnologyElsevier BV · France | 0.55Q3 | 1.43 0.49 up from 2015 | 343 | 6% | $3,810 | ||
42Journal of Molecular Pharmaceutics & Organic Process ResearchOMICS Publishing Group · United States | 0.53Q3 | 1.03 0.23 down from 2015 | 52 | 100% | — | ||
43Innovative Romanian Food BiotechnologyOARomania | 0.50Q3 | 0.65 0.19 up from 2015 | 32 | — | — | ||
44European Journal of Drug Metabolism and PharmacokineticsAdis, Springer Healthcare · France | 0.50Q3 | 1.06 0.01 down from 2015 | 192 | 16% | $2,690 | ||
45Advances in Pharmacoepidemiology & Drug SafetyOAOMICS Publishing Group · United States | 0.49Q3 | 1.16 0.56 up from 2015 | 100 | 100% | — | ||
46Journal of Pharmaceutical InvestigationSpringer Science+Business Media · South Korea | 0.46Q3 | 0.98 0.10 down from 2015 | 172 | 4% | $3,890 | ||
47Current Chemical BiologyBentham Science Publishers · Netherlands | 0.44Q3 | 0.53 0.57 down from 2015 | 60 | 4% | — | ||
48Brazilian Journal of Pharmaceutical SciencesOAUniversity of São Paulo · Brazil | 0.43Q3 | 0.53 0.25 down from 2015 | 322 | 100% | — | ||
49Medicinal ChemistryOMICS Publishing Group | 0.42Q3 | 1.07 0.15 up from 2015 | 205 | 40% | — | ||
50Recent Patents on NanotechnologyBentham Science Publishers · Netherlands | 0.39Q3 | 0.74 0.08 down from 2015 | 56 | 2% | — |
Subfields of Pharmacology, Toxicology and Pharmaceutics, compared.
Journals
Citations made in 2016. Corpus-wide, 77.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
31 additional Pharmacology, Toxicology and Pharmaceutics journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2013–2015, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2016. Publication window: 2013–2015. How these summaries are calculated
- Ranked journals
- 74
- Window papers (baseline)
- 59,061 +5.0% from indicator year 2013
- Median OJR
- 0.61 -22.9% from indicator year 2013
- Rising journals (2025)
- 4Comparison-group list (4)
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2013–2015 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 23 | 27 | 30 | 32 | 32 | 34 | 37 | 38 | 40 | 43 | 44 | 49 | 54 | 61 | 69 | 71 | 74 | 71 | 73 | 75 | 70 | 72 | 75 | 73 | 72 | 68 | |
| Window papers (baseline) | 20,428 | 21,714 | 23,158 | 25,397 | 26,889 | 29,157 | 31,606 | 34,777 | 38,146 | 41,640 | 45,814 | 49,553 | 53,613 | 56,245 | 59,173 | 59,681 | 59,061 | 56,321 | 53,536 | 51,719 | 51,606 | 54,267 | 56,608 | 57,539 | 56,944 | 58,541 | |
| Median OJR | 0.620 | 0.717 | 0.722 | 0.88 | 0.86 | 0.83 | 0.91 | 1.11 | 0.9471 | 0.97 | 0.949 | 1.03 | 0.9469 | 0.80 | 0.70 | 0.720 | 0.61 | 0.7184 | 0.74 | 0.628 | 0.77 | 0.621 | 0.67 | 0.630 | 0.625 | 0.7176 |
| Measure | Category statistic | Eligible population |
|---|---|---|
| Journal self-citation share | Median: 2.7% | 62 journals |
| Retracted papers per 1,000 | Pooled rate: 1.221 per 1,000 | 51 journals |
| Output growth | Median: -1.6% | 60 journals |
| Open access share | Median: 44.5% | 68 journals |
| Listed APC (USD) | Median including $0 listed prices: $3,605 | 32 ranked journals with a known listed price, including $0 listed prices |
| International collaboration share | Median: 22.2% | 67 journals |
| Review share | Median: 0.4% | 68 journals |
| Articles-only OJR | Median: 0.74 | 68 journals |
| Uncited share | Median: 25.2% | 68 journals |
| Citation concentration | Median: 43.7% | 68 journals |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.